Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8736674 | The Brazilian Journal of Infectious Diseases | 2018 | 9 Pages |
Abstract
Females and patients over 50 seem to be more vulnerable to renal impairment. Potentially modifiable risk factors and exposure to tenofovir disoproxil-fumarate or ritonavir-boosted protease-inhibitors are present even in earlier stages of chronic kidney dysfunction. It remains to be determined whether early interventions including antiretroviral therapy changes (tenofovir alafenamide, cobicistat) or improving comorbidities management will improve the course of chronic kidney disease.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology and Microbiology (General)
Authors
Marina Pontello Cristelli, Joan Carles Trullà s, Federico Cofán, Naira Rico, Christian Manzardo, Juan Ambrosioni, Josep Lluis Bedini, Asunción Moreno, Fritz Diekmann, Jose Maria Miro, the CKD-H. Clinical Investigators the CKD-H. Clinical Investigators,